A Single Center, Three Period, Randomized, Three-way Crossover, Double-blind Placebo And Moxifloxacincontrolled Study To Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Venlafaxine (Primary) ; Moxifloxacin
- Indications Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
- Focus Adverse reactions
- Sponsors Pfizer
- 17 Aug 2016 Status changed from active, no longer recruiting to completed.
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 16 May 2016 Planned End Date changed from 1 Aug 2016 to 1 Jul 2016.